An isocitrate dehydrogenase (IDH) gain-of-function mutant glioma tumor specimen was used as a positive control because 2-hydroxyglutarate accumulation in such tumors reportedly inhibits α-KG-dependent dioxygenases [57–60]. This evidence concerns the gene IDH3A and central nervous system cancer.